经血源性子宫内膜干细胞及其修复外周神经损伤的应用前景

刘彦礼 牛荣成 杨芬 闫岩 林俊堂*

doi:10.16098/j.issn.0529-1356.2016.05.025

PDF(305 KB)

解剖学报 ›› 2016, Vol. 47 ›› Issue (5) : 714-720. DOI: 10.16098/j.issn.0529-1356.2016.05.025

综述

经血源性子宫内膜干细胞及其修复外周神经损伤的应用前景

刘彦礼牛荣成杨芬闫岩林俊堂*

作者信息 +

Therapeutic potential of menstrual blood derived endometrium stem cells on the repair of peripheral nerve injury

LIU Yan-li NIU Rong-cheng YANG Fen YAN Yan LIN Jun-tang*

Author information +

文章历史 +

摘要

外周神经损伤带给患者长期病痛的同时严重影响了患者的生活质量，目前临床上除显微外科手术外，移植施万细胞（SC）也成为有效的治疗方法。然而SC移植的先天不足限制了其在临床上的大规模使用，因此，干细胞治疗神经损伤逐渐成为近年来的研究热点。而近来发现的经血源性子宫内膜干细胞（MenESCs）凭借其丰富的来源，无创伤的分离方式以及较高的增殖活性和分化潜能等方面的优势获得广泛关注，并在成骨、心肌、肝脏、子宫内膜及中风等疾病的治疗过程中显示了良好的效果。因此，我们在明确外周神经损伤发生机制的基础上，着重阐明MenESCs的生物学特性及其在治疗外周神经损伤的机制，以期为MenESCs在外周神经损伤的治疗提供借鉴。

Abstract

Peripheral nerve injuries not only bring long-term pain to the patients, but also seriously affect their quality of life. Of current techniques for the treatment of peripheral nerve injuries, besides the accurate microscopic surgery, Schwann cell (SC) transplantation has become an effective treatment, which plays a key role in the response of the peripheral nervous system to axonal injury. However, several drawbacks of autologous SC transplants, such as the limited sources for harvest, donor site morbidity, and difficulty expanding cells to obtain enough for transplant, have limited their use. Therefore, stem cells based therapy for improving peripheral nerve regeneration has gradually become a research hotspot in recent years. Menstrual blood derived endometrium stem cells (MenESCs) was first reported in 2007, and gained wider attention with its accessibility, no secondary surgical risk, rich source and genetic stability. Its multipotency has been demonstrated by directly differentiating them into chondrogenic, adipogenic, osteogenic, neurogenic, and cardiogenic cell lineages using the specific differentiation culture medium. This paper focuses on evaluating the therapeutic potential of MenESCs on the repair of peripheral nerve injury, and provides references to promote the clinical application of MenESCs on the peripheral nerve regeneration.

导出引用

刘彦礼牛荣成杨芬闫岩林俊堂. 经血源性子宫内膜干细胞及其修复外周神经损伤的应用前景[J]. 解剖学报. 2016, 47(5): 714-720 https://doi.org/10.16098/j.issn.0529-1356.2016.05.025

LIU Yan-li NIU Rong-cheng YANG Fen YAN Yan LIN Jun-tang. Therapeutic potential of menstrual blood derived endometrium stem cells on the repair of peripheral nerve injury[J]. Acta Anatomica Sinica. 2016, 47(5): 714-720 https://doi.org/10.16098/j.issn.0529-1356.2016.05.025

参考文献

［1］Adams AM, Arruda EM, Larkin LM. Use of adipose-derived stem cells to fabricate scaffoldless tissue-engineered neural conduits in vitro ［J］. Neuroscience, 2012, 201:349-356.

［2］Zochodne DW. The challenges and beauty of peripheral nerve regrowth ［J］. J Peripher Nerv Syst, 2012, 17(1): 1-18.

［3］Scheib J, Hke A. Advances in peripheral nerve regeneration ［J］. Nat Rev Neurol, 2013, 9(12):668-676.

［4］Witzel C, Rohde C, Brushart TM. Pathway sampling by regenerating peripheral axons ［J］. J Comp Neurol, 2005, 485(3):183-190.

［5］Irintchev A. Potentials and limitations of peripheral nerve injury models in rodents with particular reference to the femoral nerve ［J］. Ann Anat, 2011, 193(4):276-285.

［6］Martínez de Albornoz P1, Delgado PJ, Forriol F, et al. Non-surgical therapies for peripheral nerve injury ［J］. Br Med Bull, 2011, 100:73-100.

［7］Sanberg PR, Eve DJ, Cruz LE, et al. Neurological disorders and the potential role for stem cells as a therapy ［J］. Br Med Bull, 2012, 101:163-181.

［8］Salem HK, Thiemermann C. Mesenchymal stromal cells: current understanding and clinical status ［J］. Stem Cells, 2010, 28(3):585-596.

［9］Wu Y, Zhou ShY, Xu QY. Induction and differentiation of neural precursor cells from induced pluripotent stem cells ［J］. Acta Anatomica Sinica, 2016, 47(1): 18-22. (in Chinese)

武赟, 周舒雅, 徐群渊. 从多潜能干细胞诱导成神经前体细胞及其分化探讨［J］. 解剖学报, 2016, 47(1): 18-22.

［10］Tos P, Ronchi G, Geuna S, et al. Future perspectives in nerve repair and regeneration ［J］. Int Rev Neurobiol, 2013, 109:165-192.

［11］Steward MM, Sridhar A, Meyer JS. Neural Regeneration ［J］. Curr Top Microbiol Immunol, 2013, 367:163-191.

［12］Brushart TM. Nerve Repair ［M］. Baltimore: Oxford University Press, Oxford, 2011:250-352.

［13］Stoll G, Müller HW. Nerve injury, axonal degeneration and neural regeneration: basic insights ［J］. Brain Pathol, 1999, 9(2):313-325.

［14］Lee SK, Wolfe SW. Peripheral nerve injury and repair ［J］. J Am Acad Orthop Surg, 2000, 8(4):243-252.

［15］Chen ZL, Yu WM, Strickland S. Peripheral regeneration ［J］. Annu Rev Neurosci, 2007, 30:209-233.

［16］Madduri S, Gander B. Schwann cell delivery of neurotrophic factors for peripheral nerve regeneration ［J］. J Peripher Nerv Syst, 2010, 15(2):93-103.

［17］Kingham PJ, Kalbermatten DF, Mahay D, et al. Adipose-derived stem cells differentiate into a Schwann cell phenotype and promote neurite outgrowth in vitro ［J］. Exp Neurol, 2007, 207(2):267-274.

［18］Widgerow AD, Salibian AA, Lalezari S, et al. Neuromodulatory nerve regeneration: adipose tissue-derived stem cells and neurotrophic mediation in peripheral nerve regeneration ［J］. J Neurosci Res, 2013, 91(12):1517-1524.

［19］Oliveira JT, Mostacada K, de Lima S, et al. Bone marrow mesenchymal stem cell transplantation for improving nerve regeneration ［J］. Int Rev Neurobiol, 2013, 108:59-77.

［20］Faroni A, Terenghi G, Reid AJ. Adipose-derived stem cells and nerve regeneration: promises and pitfalls ［J］. Int Rev Neurobiol, 2013, 108:121-136.

［21］Brosens I, Benagiano G. The endometrium from the neonate to the adolescent ［J］. J Matern-Fetal Neo M, 2016,29(8): 1195-1199.

［22］Gargett CE, Masuda H. Adult stem cells in the endometrium ［J］. Mol Hum Reprod, 2010, 16(11):818-834.

［23］Ulrich D, Muralitharan R, Gargett CE. Toward the use of endometrial and menstrual blood mesenchymal stem cells for cell-based therapies ［J］. Expert Opin Biol Ther, 2013, 13(10):1387-1400.

［24］Meng X, Ichim TE, Zhong J, et al. Endometrial regenerative cells: a novel stem cell population ［J］. J Transl Med, 2007, 5:57.

［25］Khoury M, Alcayaga-Miranda F, Illanes SE, et al. The promising potential of menstrual stem cells for antenatal diagnosis and cell therapy ［J］. Front Immunol, 2014, 5:205.

［26］Gargett CE, Schwab KE, Deane JA. Endometrial stem/progenitor cells: the first 10 years［J］. Hum reprod update, 2015,22(2):137-163.

［27］Patel AN, Park E, Kuzman M, et al. Multipotent menstrual blood stromal stem cells: isolation, characterization, and differentiation ［J］. Cell Transplant, 2008, 17(3):303-311.

［28］Schwab KE, Gargett CE. Co-expression of two perivascular cell markers isolates mesenchymal stem-like cells from human endometrium ［J］. Hum Reprod, 2007, 22(11):2903-2911.

［29］Masuda H, Anwar SS, Buehring HJ, et al. A novel marker of human endometrial mesenchymal stem-like cells ［J］. Cell Transplant, 2012, 21(10):2201-2214.

［30］Cervelló I, Gil-Sanchis C, Mas A, et al. Human endometrial side population cells exhibit genotypic, phenotypic and functional features of somatic stem cells ［J］. PLoS One, 2010, 5(6): e10964.

［31］Masuda H, Matsuzaki Y, Hiratsu E, et al. Stem cell-like properties of the endometrial side population: implication in endometrial regeneration ［J］. PLoS One, 2010, 5(4):e10387.［32］Du X, Yuan Q, Qu Y, et al. Endometrial Mesenchymal Stem Cells Isolated from Menstrual Blood by Adherence ［J］. Stem Cell Int, 2016, 2016: 3573846.

［33］Mehrabani D, Nazarabadi RB, Kasraeian M, et al. Growth kinetics, characterization, and plasticity of human menstrual blood stem cells［J］. Iran J Med Sci, 2016, 41(2): 132-139.［34］Patel AN, Silva F. Menstrual blood stromal cells the potential for regenerative medicine ［J］. Regen Med, 2008, 3(4):443-444.

［35］Allickson JG, Sanchez A, Yefimenko N, et al. Recent studies assessing the proliferative capability of a novel adult stem cell Identified in menstrual blood ［J］. Open Stem Cell J, 2011,3(2011):4-10.

［36］Khanjani S, Khanmohammadi M, Zarnani AH, et al. Comparative evaluation of differentiation potential of menstrual blood-versus bone marrow-derived stem cells into hepatocyte-like cells ［J］. PLoS one, 2014, 9(2): e86075.

［37］Borlongan CV, Kaneko Y, Maki M, et al. Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke ［J］. Stem Cells Dev, 2010, 19(4):439-452.

［38］Darzi S, Zarnani AH, JeddiTehrani M, et al. Osteogenic differentiation of stem cells derived from menstrual blood versus bone marrow in the presence of human platelet releasate ［J］. Tissue Eng Part A, 2012, 18(15-16):1720-1728.

［39］Hida N, Nishiyama N, Miyoshi S, et al. Novel cardiac precursor-like cells from human menstrual blood-derived mesenchymal cells ［J］. Stem Cells, 2008, 26(7):1695-1704.

［40］Rodrigues MC, Glover LE, Weinbren N, et al. Toward personalized cell therapies: autologous menstrual blood cells for stroke ［J］. J Biomed Biotechnol, 2011, 2011:194720.

［41］Li Y, Li X, Zhao H, et al. Efficient induction of pluripotent stem cells from menstrual blood ［J］. Stem Cells Dev, 2012, 22(7): 1147-1158.

［42］Cui CH, Uyama T, Miyado K, et al. Menstrual blood-derived cells confer human dystrophin expression in the murine model of Duchenne muscular dystrophy via cell fusion and myogenic transdifferentiation ［J］. Mol Biol Cell, 2007, 18(5): 1586-1594.

［43］Han X, Meng X, Yin Z, et al. Inhibition of intracranial glioma growth by endometrial regenerative cells ［J］. Cell Cycle, 2009, 8(4): 606-610.

［44］Mou X, Lin J, Chen J, et al. Menstrual blood-derived mesenchymal stem cells differentiate into functional hepatocyte-like cells ［J］. J Zhejiang Uni Sci B, 2013, 14(11): 961-972.

［45］Liu T, Huang Y, Zhang J, et al. Transplantation of human menstrual blood stem cells to treat premature ovarian failure in mouse model ［J］. Stem Cells Dev, 2014, 23(13): 1548-1557.

［46］Wu X, Luo Y, Chen J, et al. Transplantation of human menstrual blood progenitor cells improves hyperglycemia by promoting endogenous progenitor differentiation in type 1 diabetic mice ［J］. Stem Cells Dev, 2014, 23(11): 1245-1257.

［47］Lv Y, Xu X, Zhang B, et al. Endometrial regenerative cells as a novel cell therapy attenuate experimental colitis in mice ［J］. J Transl Med, 2014, 12(1): 344.

［48］Alcayaga-Miranda F, Cuenca J, Martin A, et al. Combination therapy of menstrual derived mesenchymal stem cells and antibiotics ameliorates survival in sepsis ［J］. Stem Cell Res Ther, 2015, 6(1): 1-13.

［49］Sun P, Liu J, Li W, et al. Human endometrial regenerative cells attenuate renal ischemia reperfusion injury in mice ［J］. J Transl Med, 2016, 14(1): 1.

［50］Borlongan CV, Glover LE, Tajiri N, et al. The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disorders ［J］. Prog Neurobiol, 2011, 95(2):213-228.

［51］Azedi F, Kazemnejad S, Zarnani AH, et al. Differentiation potential of menstrual blood-versus bone marrow-stem cells into glial-like cells ［J］. Cell Biol Int, 2014, 38(5):615-624.

［52］Zemelko VI, Kozhucharova IV, Kovaleva ZV, et al. Brain-derived neurotrofic factor (BDNF) secretion of human mesenchymal stem cells isolated from bone marrow, endometrium and adipose tissue ［J］. Cell Tissue Biol, 2014, 56(3): 204-211.

［53］De Miguel MP, Fuentes-Julian S, Blazquez-Martinez A, et al. Immunosuppressive properties of mesenchymal stem cells: advances and applications ［J］. Curr Mol Med, 2012, 12(5): 574-591.

［54］Abumaree M, Al Jumah M, Pace RA, et al. Immunosuppressive properties of mesenchymal stem cells ［J］. Stem Cell Rev, 2012, 8(2): 375-392.

［55］Abrams MB, Dominguez C, Pernold K, et al. Multipotent mesenchymal stromal cells attenuate chronic inflammation and injury-induced sensitivity to mechanical stimuli in experimental spinal cord injury ［J］. Resto Neurol Neuros, 2009, 27(4): 307-321.

［56］Park SS, Byeon YE, Ryu HH, et al. Comparison of canine umbilical cord blood-derived mesenchymal stem cell transplantation times: involvement of astrogliosis, inflammation, intracellular actin cytoskeleton pathways, and neurotrophin-3 ［J］. Cell Transplant, 2011, 20(11-12): 1867-1880.

［57］Du J, Hu GQ, Deng L, et al. Neuroprotective effect of grafting thyroid hormone-induced neural stem cells on chronic experimental allergic encephalomyelitis ［J］. Acta Anatomica Sinica, 2015, 46(1): 13-19. (in Chinese)

杜杰, 胡光强, 邓莉, 等. 甲状腺激素诱导的神经干细胞移植对慢性实验性变态反应性脑脊髓炎的神经保护作用［J］. 解剖学报, 2015, 46(1): 13-19.

［58］Gargett CE. Uterine stem cells: What is the evidence ［J］? Hum Reprod Update, 2007, 13(1):87-101.

［59］Tomita K, Madura T, Mantovani C, et al. Differentiated adipose-derived stem cells promote myelination and enhance functional recovery in a rat model of chronic denervation ［J］. J Neurosci Res, 2012, 90(7):1392-1402.

［60］Sanberg PR1, Eve DJ, Cruz LE, et al. Neurological disorders and the potential role for stem cells as a therapy ［J］. Br Med Bull, 2012,101:163-181.

［61］Zemelko VI, Kozhukharova IB, Alekseenko LL, et al. Neurogenic potential of human mesenchymal stem cells isolated from bone marrow, adipose tissue and endometrium: a comparative study ［J］. Cell Tissue Biol, 2013, 55(2): 101-110.